---
title: "United Therapeutics Corporation to Report Fourth Quarter and Full Year 2025 Financial Results"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/275600059.md"
datetime: "2026-02-11T12:00:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275600059.md)
  - [en](https://longbridge.com/en/news/275600059.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275600059.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/275600059.md) | [English](https://longbridge.com/en/news/275600059.md)


# United Therapeutics Corporation to Report Fourth Quarter and Full Year 2025 Financial Results

United Therapeutics Corporation will report its fourth quarter and full year 2025 financial results before the market opens on Wednesday, February 25, 2026. The results will be released via a press release at approximately 6:30 a.m. Eastern Time. A public webcast to discuss the results will be held on Wednesday, February 25, 2026, at 9:00 a.m. Eastern Time and can be accessed through United Therapeutics’ website at United Therapeutics’ website (here). A rebroadcast of the webcast will be available for one year at the same location. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260211483086) on February 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### 相關股票

- [United Therap (UTHR.US)](https://longbridge.com/zh-HK/quote/UTHR.US.md)

## 相關資訊與研究

- [United Therapeutics Insider Sold Shares Worth $5,006,100, According to a Recent SEC Filing](https://longbridge.com/zh-HK/news/281244311.md)
- [Assenagon Asset Management S.A. Buys 3,824 Shares of United Therapeutics Corporation $UTHR](https://longbridge.com/zh-HK/news/280868172.md)
- [United Therapeutics Insider Sold Shares Worth $786,032, According to a Recent SEC Filing](https://longbridge.com/zh-HK/news/281244273.md)
- [United Therapeutics Director Sold Shares Worth Over $1.0M](https://longbridge.com/zh-HK/news/280686000.md)
- [These Analysts Increase Their Forecasts On United Therapeutics After Upbeat Q4 Earnings](https://longbridge.com/zh-HK/news/277085456.md)